Oncology Institute (DFPH) Payables (2020 - 2026)

Oncology Institute (DFPH) has reported Payables for 7 consecutive years, with $47.6 million the latest figure, recorded in Q1 2026.

• Payables for Q1 2026 came in at $47.6 million, up 62.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $47.6 million (up 62.68% YoY), and the FY2025 annual result was $43.2 million, up 77.47% from the prior year.
• Payables was $47.6 million for Q1 2026 at Oncology Institute, up from $43.2 million in the prior quarter.
• Over five years, Payables peaked at $47.6 million in Q1 2026 and troughed at $9.4 million in Q4 2022.
• Average Payables over 5 years is $22.1 million, with a median of $15.8 million recorded in 2024.
• The widest YoY moves for Payables: up 50881.5% in 2022, down 39.76% in 2022.
• Over 5 years, Payables stood at $9.4 million in 2022, then surged by 53.96% to $14.4 million in 2023, then soared by 68.58% to $24.3 million in 2024, then surged by 77.47% to $43.2 million in 2025, then rose by 10.39% to $47.6 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $47.6 million in Q1 2026, $43.2 million in Q4 2025, and $35.6 million in Q3 2025.